Ya Tai Pharmaceutical

Zhejiang Yatai Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company focused on the development, production, and sale of chemical drugs and active pharmaceutical ingredients (APIs). The company is particularly recognized for its extensive portfolio of anti-infective medications, including various generations of cephalosporins and macrolide antibiotics. In addition to its strength in infectious diseases, Yatai Pharmaceutical produces treatments for digestive system disorders, cardiovascular conditions, and respiratory ailments. The firm operates multiple large-scale, GMP-certified manufacturing bases that support both its proprietary product lines and its contract development and manufacturing organization (CDMO) services. Headquartered in Shaoxing, Zhejiang Province, the company has been listed on the Shenzhen Stock Exchange since 2010. Yatai Pharmaceutical continues to play a significant role in the domestic Chinese healthcare market while maintaining export capabilities for its API and finished dosage forms.